» Articles » PMID: 23001805

Obliterative (constrictive) Bronchiolitis

Overview
Date 2012 Sep 25
PMID 23001805
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Obliterative bronchiolitis (OB) (formerly termed bronchiolitis obliterans), is a rare fibrotic disorder involving terminal and respiratory bronchioles. The term constrictive bronchiolitis is synonymous with OB. Clinically, OB is characterized by progressive (often fatal) airflow obstruction, the absence of parenchymal infiltrates on chest radiographs, a mosaic pattern of perfusion on high-resolution computed tomographic scan, poor responsiveness to therapy, and high mortality rates. Most cases of OB occur in the context of a specific risk factor. Currently, most cases of OB occur in lung transplant recipients with chronic allograft rejection or hematopoietic stem cell transplant (HSCT) recipients with graft versus host disease (GVHD). Other causes of OB include connective tissue disease (CTD) (particularly rheumatoid arthritis); lower respiratory tract infections; inhalation injury; exposure or inhalation of toxic fumes, metals, dusts, particulate matter, or pollutants; occupational exposures; drug reactions; consumption of uncooked leaves of Sauropus androgynus; chronic hypersensitivity pneumonia; diffuse neuroendocrine cell hyperplasia; miscellaneous. When no cause is identified, the term cryptogenic obliterative bronchiolitis is used. This review discusses the salient clinical, radiographic, and histological features of OB and presents a management approach.

Citing Articles

Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib.

Gambale C, Prete A, Romei C, Celi A, Elisei R, Matrone A Eur Thyroid J. 2024; 13(5).

PMID: 39136571 PMC: 11466268. DOI: 10.1530/ETJ-24-0189.


Longitudinal lung function trajectories in response to azithromycin therapy for chronic lung disease in children with HIV infection: a secondary analysis of the BREATHE trial.

Madanhire T, McHugh G, Simms V, Ngwira L, Gonzalez-Martinez C, Semphere R BMC Pulm Med. 2024; 24(1):339.

PMID: 38997676 PMC: 11245797. DOI: 10.1186/s12890-024-03155-x.


Vaping-associated constrictive bronchiolitis.

Carey L, Johnson K, Villalba J, Baqir M Respir Med Case Rep. 2024; 51:102062.

PMID: 38988476 PMC: 11234146. DOI: 10.1016/j.rmcr.2024.102062.


Single-cell resolution of human airway epithelial cells exposed to bronchiolitis obliterans-associated chemicals.

Chu C, Kim S, Pryhuber G, Mariani T, McGraw M Am J Physiol Lung Cell Mol Physiol. 2023; 326(2):L135-L148.

PMID: 38084407 PMC: 11279737. DOI: 10.1152/ajplung.00304.2023.


"The effect of 48-weeks azithromycin therapy on levels of soluble biomarkers associated with HIV-associated chronic lung disease".

Hameiri-Bowen D, Yindom L, Sovershaeva E, Bandason T, Mayini J, Rehman A Int Immunopharmacol. 2023; 116:109756.

PMID: 36682262 PMC: 10914635. DOI: 10.1016/j.intimp.2023.109756.